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Cancer cells are surrounded by a mechanically and biochemically distinct microenviron-
ment that undergoes dynamic changes throughout the neoplastic progression. During 
this progression, some cancer cells acquire abnormal characteristics that potentiate 
their escape from the primary tumor site, to establish secondary tumors in distant 
organs. Recent studies with several human cancer cell lines have shown that the altered 
physical properties of tumor cells, such as their ability to apply high traction forces to 
the surroundings, are directly linked with their potential to invade and metastasize. To 
test the hypothetical interconnection between actomyosin-mediated traction forces 
and invasion potential within 3D-microenvironment, we utilized two canine mammary 
tumor cell lines with different contractile properties. These cell lines, canine mammary 
tumor (CMT)-U27 and CMT-U309, were found to have distinct expression patterns of 
lineage-specific markers and organization of actin-based structures. In particular, CMT-
U309 carcinoma cells were typified by thick contractile actomyosin bundles that exerted 
high forces to their environment, as measured by traction force microscopy. These high 
contractile forces also correlated with the prominent invasiveness of the CMT-U309 cell 
line. Furthermore, we found high contractility and 3D-invasion potential to be dependent 
on the activity of 5′AMP-activated protein kinase (AMPK), as blocking AMPK signaling 
was found to reverse both of these features. Taken together, our findings implicate that 
actomyosin forces correlate with the invasion potential of the studied cell lines.
Keywords: canine mammary tumor, breast cancer, actin cytoskeleton, invasion, contractility, actomyosin forces, 
aMP-activated protein kinase, traction force imaging
inTrODUcTiOn
Progression of breast cancer into a metastatic disease is a major clinical problem. In normal mam-
mary gland, the integrity of the epithelia is maintained by the contractile actomyosin bundles that 
provide tension for the integration of cellular junctions (1). However, during cancer progression, 
changes in the biophysical properties of the tumor stroma or defects in the mechanosensitive path-
ways of the epithelial cells may lead to deregulation of these actomyosin bundles and subsequently 
induce alterations in the intracellular forces (2). As cells start to exert abnormal forces, epithelial 
integrity may be compromised, allowing the escape of transformed cells from the primary tumor site. 
Besides the role of actomyosin forces in the maintenance of normal cell–cell junctions, actomyosin 
bundles provide traction forces through the integrin-based adhesions that enable cells to grip to the 
underlying substrate, migrate, and modify the environment (3). During invasion, the transformed 
cells rely on these actomyosin forces in penetrating the surrounding tissue and the potential to 
invade has thus been directly linked with abnormally high cellular forces (4–8).
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While most of the cancer cell invasion studies have been 
performed by utilizing either human cell lines or induced 
mouse tumors, canine tumors have become an attractive 
alternative and natural model to study many carcinomas due 
to the clear histopathological similarities in comparison with 
human cancers (9–11). Canine mammary tumors (CMTs) are 
the most frequent neoplasms of the female dogs, about three 
times more common than breast cancer in women and provide 
a comparative model for the heterogeneous group of human 
breast cancers (12–15). In addition to the clear histopatho-
logical similarities, canine share the same risk factors for the 
onset of this disease, including obesity, hormones, and genetic 
alterations (16, 17). Additionally, the expression of several 
lineage-specific markers is identical in canine and human and 
immunohistochemically similar mammary tumor subtypes 
and mammary pre-neoplasias have been detected (15, 18, 19). 
These data support the usefulness of these spontaneous carci-
nomas as a model for studying specific breast cancer subtypes 
and in understanding the mechanisms of cancer cell invasion.
In this study, we characterized two distinct CMT  cell lines, 
CMT-U27 and CMT-U309, in respect of their lineage-specific 
markers and actin cytoskeleton. Additionally, as these cells were 
displaying very different organization of actin-based structures, 
we wanted to test the possible interconnection between con-
tractile forces and invasion in 3D environment. The studied cell 
lines belonged to different subcategories of mammary tumors: 
CMT-U27 representing a simple carcinoma and CMT-U309 
representing a spindle cell carcinoma (20, 21). Simple carci-
nomas are composed of only one cell type, resembling either 
luminal epithelial or myoepithelial cells (22), while spindle cell 
carcinomas of the breast typically contain clusters of elongated 
cells, which resemble more mesenchymal than epithelial type of 
cells and are rare and aggressive subtypes of mammary tumors 
both in human and dog (23–25). As expected, analysis of these 
two cell lines with several lineage-specific markers revealed clear 
differences between the cell lines, showing that spindle carcinoma 
and simple carcinoma cells expressed predominantly basal or 
luminal cytokeratin markers, respectively. Of novel significance, 
CMT-U309 cells displayed greater number of mature actomyosin 
bundles and exerted significantly larger contractile forces in 
comparison with CMT-U27 cells. These high cell-mediated 
forces were also linked to the invasion potential of this cell line, 
while each of these effects were abolished by inhibition of 5′ 
AMP-activated protein kinase (AMPK) signaling. Our findings, 
therefore, implicate AMPK signaling as a key regulator of both 
actin-based structures and invasiveness in CMT-U309 cells and 
further supports the findings on the role of biophysical properties 
of the cells in cancer cell invasion.
MaTerials anD MeThODs
cell culture
Canine mammary tumor-U27 and CMT-U309 CMT cell lines 
(20, 21) were a kind gift from Prof. Eva Hellmen at Uppsala 
University. CMT-U27 was isolated from simple carcinoma and 
CMT-U309 from spindle cell tumor. Cells were cultured in 
RPMI 1640 with 10% FBS and penicillin–streptomycin in an 
incubator with 5% CO2, at +37°C temperature and were plated 
on dishes 1 day prior to experiments.
immunofluorescence Microscopy
Cells were cultured on glass coverslips, washed with PBS and 
fixed with 4% PFA. Fixed cells were permeabilized with 0.1% 
Triton X-100 in TBS for 5′ and moved to 0.2% Dulbecco/BSA. 
Immunofluorescence stainings were performed as described 
previously (26) and were repeated at least three times. The follow-
ing primary antibodies were used in stainings: anti-E-cadherin 
(#14472, Cell Signaling Technology, Inc., Danvers, MA, USA), 
anti-vimentin (#5741, Cell Signaling Technology, Inc., Danvers, 
MA, USA), and anti-vinculin antibody (1:50) (hVin-1, Sigma, 
Saint Louis, MO, USA). The following secondary antibod-
ies were used to detect the primary antibodies: Alexa Fluor 
α-rabbit 488 and α-mouse 568 (Life Technologies™, Carlsbad, 
CA, USA). Other reagents: Alexa-488- and -647-Phalloidins 
were used to visualize actin cytoskeleton in 1:200 dilution (Life 
Technologies™, Carlsbad, CA, USA), DAPI for DNA (Life 
Technologies™, Carlsbad, CA, USA), and DABCO/Mowiol was 
used in mounting. The images were acquired with Leica DM6000 
upright fluorescence wide field microscope equipped with 
Hamamatsu Orca-Flash4.0 V2 sCMOS camera.
Western Blotting
Cells were washed with PBS and lysed in 1% Triton X-100/PBS 
with protease and phosphatase inhibitor cocktail sets (539131 
and 539131, Calbiochem, San Diego, CA, USA). Protein 
concentrations were measured with Qubit® Protein Assay Kit 
(ThermoFisher Scientific, Waltham, MA, USA). Sample loading 
buffer 4× LSB-DTT buffer was added to lysates and samples 
were boiled for 5′ before loading the samples in SDS-PAGE gels. 
Semidry transfer and Immobilon-P Membrane, PVDF filter 
(Millipore, Billerica, MA, USA) was used for blotting. Mixture 
of 5% milk/BSA was used for blocking. Following antibodies 
were used for detection of specific proteins: mouse anti-p63 
(4A4, Abcam, Cambridge, UK), rabbit anti-slug (#9585, Cell 
Signaling Technology, Inc., Danvers, MA, USA), mouse anti-
E-cadherin (#14472, Cell Signaling Technology, Inc., Danvers, 
MA, USA), rabbit anti-N-cadherin (13116, Cell Signaling 
Technology, Inc., Danvers, MA, USA), rabbit anti-claudin-1 
(#13255, Cell Signaling Technology, Inc., Danvers, MA, USA), 
mouse anti-cytokeratin 5 (XM26, Abcam, Cambridge, UK), rab-
bit anti-cytokeratin 14 (EPR17350, Abcam, Cambridge, UK), 
anti-Pan-keratin mAb (C11, #4545, Cell Signaling Technology, 
Inc., Danvers, MA, USA), rabbit anti-vimentin (#5741, Cell 
Signaling Technology, Inc., Danvers, MA, USA), rabbit anti-
P-Thr172-AMPK (#4188, Cell Signaling Technology, Inc., 
Danvers, MA, USA), anti-calponin 1/2/3 Antibody (FL-297, 
Santa Cruz, CA, USA), anti-tropomyosin 1, 2, 3 (TM31; T2780, 
Sigma, Saint Louis, MO, USA), rabbit anti-P-thr18/ser19- 
myosin light chain (MLC) (3674, Cell Signaling Technology, 
Inc., Danvers, MA, USA), mouse anti-β-actin (clone AC-15, 
Sigma, Saint Louis, MO, USA), mouse anti-smooth muscle actin 
(α-SMA, clone 1A4, A5228, Sigma, Saint Louis, MO, USA), 
mouse anti-GAPDH (G8795, Sigma Aldrich, Saint Louis, MO, 
USA). Anti-mouse or -rabbit HRP-linked secondary antibodies 
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(Cell Signaling Technology, Inc., Danvers, MA, USA) and 
Western HRP substrate (Luminata™Crescendo, WBLUR0100, 
Millipore, Billerica, MA, USA) were used for chemilumines-
cence detection of the protein bands. All Western Blot experi-
ments were repeated at least three times.
cell Proliferation assays
Cell proliferation assays were performed with Cell IQ live-cell 
imaging setup as in wound-healing assays. For measuring cell 
doubling time, CMT-U309 and CMT-U27 cells were sparsely 
plated on 12-well plate 1 day before the actual experiment. The 
following day, cell growth/proliferation was monitored for 24 h 
and images were acquired every 30 min. Cell growth rate (GR) 
was calculated by using the formula: GR N t N
t
=
ln( ( ) / ( ))0 , and 
cell doubling time was calculated: ln( )2
GR
, where N (t) = number 
of cells in the end of experiment, N(0) is cell number in the 
beginning and t = time in hours.
contractile Function
Cells were cultured on fibronectin (FN)-coated, shape- 
determined micropatterns (CYTOOchips™, Grenoble, France) 
for 6 h and fixed with 4% PFA for 20′. Actin cytoskeleton was 
stained with Alexa-488-Phalloidin and nuclei with DAPI. Analysis 
of contractile function is based on the curvature of the formed thick 
contractile actomyosin bundle (see also Figure 3B). Radius of cur-




/ 2 2 2( ) + , 
where L = length and w = width. Measurements of cell edges were 
done with ImageJ program.
Traction Force Microscopy (TFM)
To measure cell-exerted traction forces, CMT-U27 and -U309 
cells were cultured for 2–4 h on elastic collagen-1-coated pol-
yacrylamide-based gel substrates of known stiffness (Young’s 
Modulus/elastic modulus = 11 kPa). Substrates were surface-
coated with sulfate fluorescent microspheres (Invitrogen, 
Carlsbad, CA, USA, diameter 200  nm). Single isolated cells 
together with the underlying microspheres were imaged with 3I 
Marianas imaging system (3I intelligent Imaging Innovations, 
Germany), at multiple locations. To perform the imaging, a 
63×/1.2  W C-Apochromat Corr WD =  0.28 M27 objective 
was used. The system was placed in a heated sample chamber 
(+37°C) and controlled for CO2. Following live cell imaging, 
the cells were detached from the substrates with 10 × Trypsin 
(Lonza Group, Basel, Switzerland) and a second set of micro-
sphere images were obtained in a cell-free configuration. These 
images served as reference. Cell-exerted traction forces cause 
displacement of microspheres within the elastic substrate and 
spatial maps of microsphere displacements were achieved by 
comparing the reference microsphere images together with 
the experimental images. With knowledge of the cell-exerted 
displacement field, substrate stiffness (11 kPa), and a manual 
trace of the cell boundary, we computed the cell-exerted trac-
tion field using Fourier Transform Traction Cytometry (27, 28). 
From the traction field, we computed the root mean squared 
magnitude.
Wound-healing assay
Wound-healing assays were performed to study cell migra-
tion by using Cell IQ live-cell imaging setup consisting of a 
microscope (Nikon) equipped with 10×/0.30 Ph1 objective and 
an incubator at +37°C with CO2. Images were captured with 
Qimaging Retiga EXi camera using Cell IQ Imagen software. 
For wound-healing assay, CMT-U309 and CMT-U27 cells were 
grown to confluency on 12-well plate (CellStar). The wound 
(gap) was created by scratching the confluent monolayer with a 
200 µl pipette tip, and the debris was removed immediately by 
rinsing twice with DMEM. Cells were monitored for 24 h and 
images were acquired every 30  min. Data were analyzed using 
Cell IQ Analyser. The half-closure time was calculated by using 
the formula: t1 2/ gap Initial gap Area
2xslope
= . Gap area was measured 
and plotted as a function of time. Cell migration rate (vmigration, 
micrometer per hour) was calculated from the slope of this plot: 
υ migration= slope
2xl
, where v = velocity and l = length of the gap.
3D cell culture
ECM gel from Engelbreth-Holm-Swarm murine sarcoma (Sigma 
E1270) was prepared according to manufacturer’s instructions. 
CMT-U309 and CMT-U27 cells were trypsinized and ~5,000 
cells in DMEM were seeded on top of the matrigel-coated eight-
chamber slides. 3D spheroids were observed under microscope 
daily for 2 weeks.
Manipulation of aMPK activity
For the inhibition of AMPK activity, cells were treated with 
AMPK inhibitor, compound C (Sigma-Aldrich). On 2D cultures, 
final concentration of compound C was 5 μM and incubation 
time 3–6 h.
In 3D spheroid cultures, 15 µM compound C was applied on 
cells for 6 days to completely inhibit AMPK activity. For the acti-
vation of AMPK activity, cells were treated with 25 μM AICAR 
(Sigma Aldrich, Saint Louis, MO, USA) for 16 h.
statistical analyses and Data Presentation
SDs and statistically significant difference between means of two 
groups (t-test) were analyzed in Microsoft Excel 2013. Box charts 
were done with OriginPro 8.6 program (Whisker range 5–95, 
showing outliers) and column charts were done with Microsoft 
Excel 2013.
resUlTs
cMT-U27 and cMT-U309 cell lines exhibit 
Distinct Morphological Features and 
Differential expression of lineage-specific 
Markers
We examined the morphological features and a set of lineage-
specific markers of the two established CMT  cell lines, simple 
carcinoma CMT-U27, and spindle cell carcinoma CMT-U309 
FigUre 1 | Continued  
Morphology and expression of lineage-specific markers in canine mammary 
tumor (CMT)-U27 and -U309 cell lines. (a) CMT-U27 and -U309 cells exhibit 
distinct morphological features, U27 cells had more variation in cell size and 
shape, while U309 were mostly elongated and typically not contact inhibited 
by the confluency. Actin cytoskeleton is stained with phalloidin and nuclei with 
DAPI. Scale bar 10 μm. (B) Western Blotting from cellular lysates revealed 
that epithelial cell–cell contact proteins E-cadherin and claudin-1 are absent 
from CMT-U309 cells, while these cell express N-cadherin. In contrast, 
CMT-U27 cells possess expression of both E-cadherin and claudin-1, typical 
for luminal epithelial cells. Western Blot experiments were repeated at least 
three times. (c) Proliferation rates and average cell doubling times of 
CMT-U27 and CMT-U309 cell lines were measured from sparsely growing 
cultures in an o/n experiment (see Materials and Methods for details). Values 
are presented in box-plots, where the median is indicated by the central bar. 
5/95 percentile whiskers with outliers are shown; n = 3–6.  
(D) Western blot experiments from the cellular lysates of CMT-U27 and -U309 
cell lines showed that CMT-U309 cells express both p63 and slug, typical 
markers for the basal breast epithelial cells, while CMT-U27 cells possess 
almost non-detectable levels of these proteins. Western Blot experiments 
were repeated at least three times. (e) Mesenchymal marker vimentin is 
highly expressed in CMT-U309 cells as shown by western blots from the 
cellular lysates of CMT-U27 and -U309 cells as well as immunofluorescence 
stainings with anti-vimentin antibody (F). Nuclei are visualized with DAPI. 
Scale bar 10 μm. (g) Expression of cytokeratins was studied with anti-CK5 
anti-CK14 and anti-Pan-Keratin antibody recognizing CK4, 5, 6, 8, 10, 13, 18 
by Western Blotting from cellular lysates. Expression of CK5 was detected in 
both studied cell lines, while CK14 was detected only in CMT-U309 cells. 
Detection with Pan-Keratin ab showed differences in the expression of CK8 
and 18 (53 and 48 kDa, respectively) that are typical for the luminal epithelial 
cells. Western Blot experiments were repeated at least three times.
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(20, 21). Some of these markers have previously been shown by 
other studies (20, 21, 29). CMT-U27 exhibited pleomorphic cells 
as shown in Figure 1A, left panel. These cells were contact inhib-
ited by increasing cell confluency, while the spindle carcinoma 
cells, CMT-U309, had an elongated-morphology and tended to 
overgrow the neighboring cells (Figure  1A, right panel). The 
examination of epithelial cell adhesion proteins showed that 
E-cadherin and claudin-1 are not expressed in CMT-U309 cells 
(Figure  1B). In contrast, CMT-U309 cells were showing high 
levels of N-cadherin (Figure 1B), a protein, which is often asso-
ciated with the decrease in E-cadherin expression in so-called 
FigUre 1 | Continued
cadherin switch during epithelial-to-mesenchymal transition 
and linked to metastatic breast cancer (30, 31). CMT-U27 cells 
did not show any expression of N-cadherin but had clear expres-
sion of epithelial adhesion proteins E-cadherin and claudin-1 
(Figure 1B).
The average cell doubling time for CMT-U27 and CMT-
U309 was found to be 28.5 and 21.1 h, respectively (Figure 1C). 
Faster proliferating spindle carcinoma CMT-U309 cells showed 
clear reactivity for the basal cell marker p63, while CMT-U27 
cells expressed very low levels of this marker (Figure  1D). 
Transcription factor p63 has been shown to be highly expressed 
in both human and canine spindle cell mammary cancer tumors 
(32, 33). CMT-U309 cells also expressed snail family transcrip-
tion repressor slug that has been implicated in maintaining the 
basal phenotype [reviewed in Ref. (34)], while CMT-U27 cell 
line had almost non-detectable levels of this protein (Figure 1D). 
Furthermore, CMT-U27 cells did not show any reactivity for the 
mesenchymal marker vimentin, while it was highly expressed in 
CMT-U309 spindle cells (Figures 1E,F).
Cytokeratins (CKs) play a significant role in the progression of 
mammary tumors (35). Therefore, we examined the expression 
of CKs 4, 5, 6, 8, 10, 13, 14, and 18 by utilizing a Pan-Keratin 
antibody as well as by using a specific antibody against CK5 
and CK14. Both CMT-U27 and CMT-U309 showed similar 
expression of CK5, as detected by western blotting (Figure 1G). 
Basal CK14 was distinctly expressed in the spindle carcinoma 
cells (Figure  1G). The western blot analyses with Pan-Keratin 
antibody showed similar pattern of protein bands between these 
cell lines. However, the intensity of bands corresponding to the 
FigUre 2 | Canine mammary tumor (CMT)-U27 and CMT-U309 cells display differential organization of actin cytoskeleton and expression of actin-associated 
proteins. (a) Simple carcinoma cells CMT-U27 possess both thick contractile actomyosin bundles as well as thinner actin-based structures both perpendicular and 
parallel to the leading edge of the cells. Spindle carcinoma cells, CMT-U309, have predominantly thick straight actomyosin bundles that are connected to focal 
adhesion sites from their both ends. Magnification of the cell edges of both cell lines are shown below. Phalloidin-green, focal adhesion marker vinculin-red and 
DAPI-blue. Scale 10 μm. (B) Western blot analyses of cellular lysates from the studied cell lines showed that both cell lines express high levels of β-actin, while high 
expression of smooth muscle actin, α-SMA, was detected only in spindle cell carcinoma U309. These cells were devoid of non-muscle myosin as detected with the 
phospho-thr18/ser19-myosin light chain (MLC) antibody. Differential expression of calponin-1 and specific tropomyosin isoforms was also detected between these 
cell lines: CMT-U309 cells expressed high levels of calponin-1, typical for basal cells, while this protein was not detected from the lysates of CMT-U27 cells. 
CMT-U27 expressed mainly tropomyosin isoform, Tm3, while CMT-U309 cells expressed Tm1 and Tm2. Western Blot experiments were repeated at least three 
times. (c) Expression of active form of AMP-activated protein kinase (AMPK) kinase, phospho-Thr172-AMPK, was analysed from the cell lines as it has been linked 
to maturation of thick contractile actomyosin bundles (26). High levels of P-Thr172-AMPK was detected from the lysates of CMT-U309 cells, correlating with the 
appearance of thick actomyosin bundles in these cells.
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size of luminal epithelial markers CK8 and CK18 (53 and 48 kDa, 
respectively), showed clearly lower levels in CMT-U309 cell line 
(Figure  1G). Thus, the expression patterns, verified by several 
lineage-specific markers, were suggestive for distinct luminal- 
and basal-like features within the studied cell lines.
Organization and expression of actin 
cytoskeleton-associated Proteins in 
cMT-U27 and -U309 cell lines
Actin cytoskeleton undergoes dramatic reorganization dur-
ing the process of malignant transformation (36). During this 
transformation, several actin-binding proteins are known to 
be deregulated and contribute to the development of abnormal 
adhesive and migratory properties of the cancer cells. We exam-
ined the organization of actin cytoskeleton as well as expression 
of cytoskeletal proteins in CMT-U27 and CMT-U309 cancer cell 
lines (Figure  2A). CMT-U27 cells exhibited variable organiza-
tion of their actin cytoskeleton, including both thick contractile 
bundles as well as thin actin-based structures both parallel and 
perpendicular to the leading edge of the cells (Figure 2A). These 
thin structures resembled structures that act as precursors for 
the mature thick contractile actomyosin bundles (26, 37, 38). In 
contrast, CMT-U309 cells had very prominent, thick contractile 
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actin-based bundles, bound to focal adhesion sites from their 
both ends (Figure 2A).
Both CMT-U27 simple carcinoma and CMT-U309 spindle car-
cinoma cells appeared to have similar expression level of β-actin 
(Figure  2B). Additionally, spindle carcinoma cells expressed 
high levels of smooth muscle actin (α-SMA) and calponin-1 
(Figure 2B), typical for these type of carcinoma cells. In respect 
of non-muscle myosin and high molecular weight tropomyosins 
(Tm1, 2, and 3), these cell lines showed also clear differences. 
CMT-U27 possessed high levels of phosphorylated non-muscle 
MLC (P-thr18/ser19-P-MLC), indicative of active myosin that 
is required for the contraction. In contrast, in CMT-U309, its 
level was almost non-detectable (Figure 2B). These cell lines had 
also distinct expression patterns of tropomyosins as CMT-U309 
showed predominantly expression of Tm1 and Tm2, while CMT-
U27 had high expression of Tm3 isoform (Figure 2B).
As the maturation of contractile actomyosin bundles from 
their precursor was recently found to be dependent on the activ-
ity of 5′ AMPK (26), we examined the levels of active AMPK, 
P-Thr-172 AMPK, from the lysates of both CMT  cell lines 
(Figure 2C). Lysates from CMT-U27 cells contained low levels 
of active AMPK. In contrast, CMT-U309 cells were found to have 
high levels of P-thr172-AMPK, correlating well with the presence 
of thick, mature actin-based bundles in these cells. The results 
suggest that the high AMPK kinase activity could be responsible 
for the great number of mature actomyosin bundles in CMT-
U309 cells.
cMT-U309 cells Display high contractile 
Forces
Actin-based structures provide force for many cellular processes 
[reviewed in Ref. (39)]. These contractile actomyosin forces 
can be exerted through the adhesion sites to the surround-
ing extracellular matrix as traction forces. We analyzed the 
contractile properties of CMT-U27 and CMT-U309 cell lines 
by utilizing FN-coated shape-determined micropatterns on 2D 
cultures (CYTOOchips™) (Figures  3A,B). Cells cultured on 
these patterns organize their mature contractile bundles at the 
edges of these patterns and precursor structures are typically 
found behind the formed leading edge of the cell, at the arc of the 
micropattern (Figure 3A). The curvature of the formed contrac-
tile bundle is related to its contractility. Contractile function of 
the cells, cultured on these patterns, can be calculated as radius 
of curvature, R, as described in Figure 3B. Based on this analysis 
method, CMT-U27 cells were significantly less contractile than 
CMT-U309 cells (Figure 3C).
Furthermore, we measured the cell-exerted forces directly 
by utilizing TFM. In this method, cells are cultured on an 
elastic substrate, embedded with fluorescent microspheres, 
and the cell-exerted forces cause displacement of these beads. 
With the knowledge of the microsphere displacement field and 
stiffness of the elastic substrate, cell-exerted traction forces can 
be computed. Consistent with the contractility measurements 
by using micropatterns, described above, CMT-U27 exerted 
significantly smaller traction forces than CMT-U309 cells 
(Figures 3D,E).
invasion Potential of cMT-U309 is 
Dependent on its high Traction Forces
Recent studies have shown that cell-substrate forces directly 
correlate with the invasion potential of cancer cells in 3D matrices 
and that several invasive human cancer cell lines apply higher 
forces than their non-invasive counterparts (7, 8). We compared 
the migratory properties of CMT-U27 and CMT-U309 in both 
2D cultures and in 3D matrigel cultures. The migration speed 
of CMT-U27 and CMT-U309 cells was 9.5 and 14.5  μm/h, 
respectively (see Figures 4A–C). Confocal images showed that, 
in 3D collagen cultures, the morphology of these two cell types 
were totally different (Figure 5A): CMT-U27 cells were rounded 
with cortical actin staining and bleb formation, while CMT-U309 
cells exhibited long actin-based protrusion and elongated form. 
In 3D matrigel cultures, both cell lines initially formed round 
symmetrical spheroids (Figure 5B). After 3 days in culture, the 
spindle carcinoma cells started to exhibit invasive features and 
escape from the primary structures that had already undergone 
through massive expansion (Figures  5B,C). CMT-U27 cells 
were highly proliferative but did not invade to the surrounding 
matrix, while CMT-U309 cultures showed single invading cells 
that started to form new spheroids outside the primary structures 
(Figure 5B).
Next, we examined whether the invasion potential of CMT-
U309 cell line was dependent on its contractile properties. Since 
the maturation of force-producing actomyosin bundles was 
recently shown to be controlled by AMPK (26) and CMT-U309 
cells also exhibited high levels of active AMPK (Figure  2C), 
we tested how inhibition of this kinase would affect contractil-
ity and actin-based invasion in this particular cell line. AMPK 
activity was inhibited by compound C in 3D matrigel cultures 
(Figures 6A,B). Importantly, in the inhibitor-treated 3D cultures, 
CMT-U309 cells still proliferated and formed predominantly 
symmetrical spheroid-like structures. However, their ability to 
invade was completely prevented (Figure  6A). To verify that 
AMPK inhibition actually affects the formation and morphology 
of contractile actomyosin bundles, we performed 2D cultures of 
these cells and analyzed the organization of actin cytoskeleton in 
both ctrl and inhibitor-treated cells. Inhibition of AMPK activity 
for 6 h was found to significantly decrease the amount of fully 
matured contractile actomyosin bundles and in contrast increase 
the amount of thinner precursor structures (Figures 6C,D). In 
line with this, opposite stress fiber phenotype was detected in 
CMT-U27 cells that were exposed to a commonly used AMPK 
activator, AICAR (Figure S1 in Supplementary Material), sug-
gesting that the maturation of contractile actomyosin bundles is 
dependent on AMPK activity also in these particular CMT cell 
lines. Furthermore, we analyzed whether the effect of AMPK 
inhibitor on the organization of contractile actomyosin bundles 
in CMT-U309 cells could be dependent on the expression levels 
of α-SMA, calponin-1, and tropomyosins. However, we could not 
detect any alterations in their levels in Western Blots within the 
same time frame as the reorganization of actin-based structures 
was detected (data not shown).
Moreover, we wanted to analyze how these changes in actin-
based structures after AMPK inhibition would be reflected to 
FigUre 3 | Analysis of contractile function and cell-mediated forces. (a) Canine mammary tumor (CMT)-U27 and CMT-U309 cells were cultured on 
shape-determined, fibronectin (FN)-coated micropatterns (CYTOOchips™), and visualized for the organization of actin cytoskeleton. CMT-U309 cells displayed 
again only thick straight bundles, while CMT-U27 cells had thinner structures with more variability in their organization pattern. Phalloidin-green, DAPI-blue. 
Scale bar 10 μm. (B) Contractile function of the actin-based structures was analyzed from the cells cultured on these micropatterns. Contractility is directly 




( ) +/ 2 2 2
, where L = length and w = width. (c) Mean contractile function 
of CMT-U27 and CMT-U309 cells ± SD, n = 32 (U27), n = 39 (U309). (D) Representative examples of traction force maps of CMT-U27 and CMT-U309 cells. 
Unit of stress is in pascals (Pa). (e) Root mean square tractions of CMT-U27 and CMT-U309 cells are shown in the upper graph and contractile moment in the 
lower graph. Means ± SD are shown (n = 7 for U27; n = 10 for U309).
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FigUre 4 | Migration speed of canine mammary tumor (CMT)-U27 and CMT-U309 on 2D environment. (a) Images from a wound-healing assay at different time 
points. CMT-U27 and CMT-U309 cells were grown to confluency, wounded with a pipette tip, and then imagined 24 h with automated cell IQ live-imaging platform. 
(B) Wound area recovery over time. The gap area was quantified for each time frame and for each cell line using Cell IQ Analyser. The half-closure times were 
calculated by using the formula: t1/2gap
Initial gap Area
2xslope
= . Mean ± SD is shown, n(U27) = 6 and n(U309) = 8. (c) Average migration speed (micrometers per hour) 





. Values are presented in box-plots, where the median is indicated by the 
central bar. 5/95 percentile whiskers with outliers are shown; n(U27) = 6 and n(U309) = 8.
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cell traction forces. TFM was performed in ctrl (non-treated) 
and compound C-treated CMT-U309 cells (Figure 6E). After the 
inhibition, the cell spreading area was about 80% of the size of 
untreated cells (Figure 6F), while the average Root Mean Square 
tractions in AMPK-inhibitor-treated cells were approximately 
five times smaller in comparison with ctrl cells (Figure  6G). 
The decrease in cell-mediated forces correlated well with the 
detected decrease in the amount of thick actomyosin bundles 
after AMPK inhibition (Figures  6C,D). Our results suggest 
that AMPK activity controls the maturation of force-producing 
actomyosin bundles in this cell line and that high traction forces 
are connected to the invasion potential of these canine spindle 
carcinoma cells.
DiscUssiOn
Canine mammary tumors provide a more natural model sys-
tem to study the complex biology of human breast carcinomas 
in comparison with the induced rodent tumors (15, 40, 41). In 
this study, we utilized two different subtypes of CMT cell lines, 
simple carcinoma CMT-U27 and spindle cell carcinoma CMT-
U309, to characterize their subtype-specific differences in the 
expression of lineage-specific markers as well as to clarify the link 
between actomyosin forces and invasion potential of cancer cells 
within 3D environment. We found that CMT-U27 and CMT-
U309 cell lines exhibited distinct expression patterns toward 
luminal and basal markers, respectively (Figures  1 and 2). 
Basal markers α-smooth muscle actin, calponin, vimentin, 
and p63 that were expressed by CMT-U309 have been mostly 
associated with poor prognosis in human breast cancers 
(42, 43). Of the other basal markers, only cytokeratin 5 (CK5) 
was expressed in both cell lines. CK5 is typical for progenitors 
and intermediary cells in both human and canine and approxi-
mately 75% of the canine simple carcinoma cases are known 
to express this cytokeratin isoform (44, 45). Otherwise, the 
cytokeratin expression pattern was different in between the 
cell lines, CMT-U309 expressing CK14 and CMT-U27 more 
luminal epithelial CKs (Figure  1G). Expression of epithelial 
CKs CK8, 18 and 19 are often lost during neoplastic transfor-
mation and expression of basal CKs as CK5/6, 14, and 17 start 
to dominate (46, 47). This kind of shift toward basal cytokeratin 
expression has been linked with an aggressive cancer pheno-
type in both canine and human (32, 35). In our study, the 
CMT-U309 cells with basal characteristics also appeared more 
aggressive in 3D culture setup than the luminal type CMT-U27 
cells. Additionally, these CMT-U309 cells expressed high levels 
of Tm1, which in humans is associated with malignant conver-
sion of mammary epithelium and resistance to anoikis (48).
FigUre 5 | 3D morphology and invasion potential of canine mammary tumor 
(CMT)-U27 and CMT-U309 cell lines. (a) Confocal images of CMT-U309 and 
CMT-U27 in 3D collagen matrix. CMT-U27 cells adopt round and blebbing 
conformation, while CMU309 cells exert long actin-based protrusions. 
Phalloidin-green, DAPI-pink. Scale bar 10 μm. (B) CMT cell lines have 
different invasion potential in 3D matrigel cultures. Brightfield images of 
cultures taken on days 1, 3, and 6 are shown. Both CMT-U27 and 
CMT-U309 cell lines form initially spheroid-like structures, which start to 
expand rapidly. CMT-U27 cells have deficient growth control and form very 
dense structures but do not invade, while CMT-U309 cells clearly start to 
dissociate from the original 3D spheroid and form secondary structures 
outside. Scale 100 μm. (c) Quantification of the diameter of the expanding 
cellular 3D structure 6 days after culture. Values are presented in box-plots, 
where the median is indicated by the central bar. 5/95 percentile whiskers 
with outliers are shown; n = 15.
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What is then the origin of these invasive CMT-U309 cells? 
Spindle cell carcinoma of the breast represents a sub group of 
metaplastic carcinomas, showing variability in cellular compo-
sition and features (25). There has been discrepancy about the 
genetic origin of these types of breast carcinomas, and some 
studies have proposed them to be originated from myoepithelial 
cells (24) and some from luminal cells (49). Interestingly, the 
study by Hellmen et  al. (21) showed that CMT-U309 spindle 
carcinoma cells possess plasticity and that they can give rise to 
phenotypically distinct tumor types in  vivo (21). This suggests 
that CMT-U309 CMT line could be derived from pluripotent 
stem cells. In line with that, we found that CMT-U309 cell line 
expressed high levels of slug (Figure 1D), a member of the snail 
family transcription repressors, which is associated to the main-
tenance of the mammary stem cell-like state in both human and 
mouse (34, 50). Additionally, we could not detect any claudin-1 
in CMT-U309 cells (Figure 1B) and claudin-1 has been shown to 
be repressed by slug (51, 52).
Spindle cell carcinomas are aggressive subtypes of mammary 
tumors and there are no standard treatment protocols (53). 
Canine spindle carcinoma cells, CMT-U309, possessed high 
contractility and invasion potential in 3D matrigel cultures, 
and these features were found to be dependent on high AMPK 
activity (Figures  3, 5 and 6). AMPK kinase has mainly been 
linked to the regulation of main metabolic pathways but it also 
contributes to other signaling and growth control routes (54). 
Due to its involvement in many cellular tasks, the role of AMPK 
in cancer progression has been controversial and is probably 
dependent on the cellular context. In breast cancers, this may 
potentially be dependent on the estrogen receptor status as 
estrogen has also been linked to the regulation of AMPK activ-
ity (55, 56). In CMT-U309 cells, high AMPK activity was clearly 
linked to the capability to invade (Figure  6A). Additionally, 
high AMPK activity was directly linked with the morphology 
of thick actin-based structures (Figures 2, 3 and 6). Chemical 
inhibition of AMPK activity led to a decrease in the amount of 
mature actomyosin bundles and increase in the number of thin 
precursor structures (Figures 6C,D). These findings are in line 
with the previous data on the role of AMPK in the maturation 
of muscle sarcomeres and non-muscle actomyosin bundles 
(26, 57). The change in the morphology of actomyosin struc-
tures in AMPK-inhibited cells was also directly reflected to the 
cell traction forces (Figures  3 and 6E,F). As manipulation of 
AMPK activity was not affecting the expression level of either 
α-SMA or other actin-associated factors (results not shown), 
the data indicate that changes in cell-mediated forces upon 
AMPK inhibition are observed due to disturbed maturation of 
actomyosin bundles.
In conclusion, this work shows that high actomyosin-
mediated contractility and traction forces of CMT-U309 cell 
line were associated with its invasion potential and regulated 
by AMPK (Figure 6). Such a relationship, i.e., a link between 
high traction forces and cancer cell invasion, has been reported 
for many human cancer cell lines (4, 7, 58). Exertion of high 
traction forces may be predictive of the proteolytic degradation 
of ECM by invadopodia and, in this way, promote invasive 
phenotype (59). The data support the previous notions on the 
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FigUre 6 | Continued
FigUre 6 | Continued  
Chemical inhibition of AMP-activated protein kinase (AMPK) activity in canine mammary tumor (CMT)-U309 cells blocks the invasion potential of these cells.  
(a) CMT-U309 cells were cultured in 3D matrigel either in the presence or absence of AMPK inhibitor compound C for 14 days. Brightfield images taken on day 8 
are shown. Cells incubated with the chemical compound were still forming symmetrical 3D scaffolds but their invasion capability was totally inhibited. Scale bar 
100 μm. (B) Quantification of the diameter of the formed 3D structures in matrigel between days 6 and 8. Data are presented in box-plots, where the median is 
indicated by the central bar. 5/95 percentile whiskers with outliers are shown; n = 17 for ctrl and n = 15 for compound C-treated cultures. (c) Treatment of 
CMT-U309 cells with compound C leads to decrease in the amount of thick contractile actomyosin bundles on 2D cultures as visualized by phalloidin staining. Scale 
bar 10 μm, DAPI is visualized with pink color, actin-green. (D) Lineprofiles of ctrl and compound C-treated CMT-U309 cells show decreased intensity and width of 
the fibers, indicating appearance of thinner actin-based structures in AMPK-inhibited cells. Lineprofiles were drawn 20 μm perpendicular from the edges of the cells 
as shown on the right side panels. Fluorescence intensities along the lineprofiles were measured with ImageJ. (e) Treatment of CMT-U309 cells with compound C 
leads to decreased cell-mediated traction forces. Images of representative cells and the corresponding force maps are shown. (F) Quantification of the spreading 
area and average root mean square traction forces (g) of untreated or AMPK inhibitor-treated cells. AMPK inhibition led to small decrease in cell size, while the 
difference in cell-mediated forces was significant, AMPK-inhibited cells displaying only about 20% of the original forces. Results are shown as ±SD (n = 10, U309 
ctrl cells; n = 6, U309 compound C-treated cells).
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importance of cellular forces in neoplastic progression and 
cancer cell invasion.
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FigUre s1 | AMP-activated protein kinase activation by chemical compound, 
AICAR, induces maturation of contractile actomyosin bundles in canine 
mammary tumor (CMT)-U27 cells. (a) CMT-U27 simple carcinoma cells were 
either left untreated or were treated with AICAR for 16 h. After fixation, cells were 
stained with Phalloidin-488 and DAPI to visualize cytoskeletal structures and 
nuclei. AICAR-treated cells showed clearly greater number of thick contractile 
bundles, bound to focal adhesion sites from their ends (white arrows), while ctrl 
cells displayed both precursor structures and mature bundles. Precursor network 
behind the leading edge of the cells is indicated with white brackets. Scale 
10 μm. (B) Cells exhibiting only mature, force-producing structures were 
quantified from the imaging data. 26.5% of the ctrl cells possessed only mature 
actomyosin bundles, while after AICAR-treatment the amount of these cells had 
increased to 71.9%. n(ctrl cells) = 94 and n(AICAR cells) = 114.
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